Therapies

As a result of its solid and successful experience as partner with the Italian Health System, its significant expansion into international operations and a fundamental commitment to research and development, Kedrion’s line of plasma-derived products is broad and diverse.

With treatments for many rare and debilitating diseases and conditions from hemolytic disease in newborns to immune deficiencies to hemophilia, Kedrion offers a wide and expanding array of treatments and therapies.

RARE AND ULTRA-RARE DISEASES /
COAGULATION DISORDERS

COAGADEX
Human coagulation Factor X

EMOCLOT/ EMOWIL / KLOTT*
Human coagulation Factor VIII

NUWIQ**
Human coagulation Factor VIII (rDNA), Simoctocog Alfa

WILFACTIN**
Human Von Willebrand Factor

AIMAFIX / IXED*
Human coagulation Factor IX

EMOSINT
I.m. Desmopressin

ACUTE / CRITICAL CARE
AND TRANSPLANTATION

UMAN ALBUMIN / UMAN SERUM /
ALBITAL* / ALBUMINA LFB**
Human Albumin solution

VENBIG / KEYVENB / VEBIKED
Human Hepatitis B i.v. Immunoglobulin

IMMUNOHBs / UMAN BIG / KEDHBs*
Human Hepatitis B i.m. Immunoglobulin

TETANUS GAMMA
Human Tetanus Immunoglobulin

UMAN COMPLEX / KEDCOM* / PRONATIV**
Human Prothrombin complex

AT III KEDRION / ATKED*
Human Antithrombin

K FLEBO 
Potassium aspartate

PLASMASAFE / PLASMAGRADE*
Human plasma proteins / Pharmaceutical grade plasma

MONOFERRIC**
i.m / i.v. Ferric Derisomaltose